Accueil › Maladies pulmonaires interstitielles › New York › New York City
Essais cliniques pour Maladies pulmonaires interstitielles à New York City, NY
18 études pour Maladies pulmonaires interstitielles recherchent des participants dans et autour de New York City (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
Recrutement en coursPhase 3
- Weill Cornell Medicine-New York-60569, New York
- Columbia University Medical Center-New York Presbyterian Hospital, New York
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
Recrutement en coursPhase 3
- Weill Cornell Medicine-New York-60569, New York
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Recrutement en coursPhase 2
- NYU Langone Health, New York
- Icahn School of Medicine at Mount Sinai, New York
- Weill Cornell Medicine, New York
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Recrutement en coursPhase 3
- USA005, New York
A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease
Recrutement en coursPhase 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
Recrutement en coursPhase 3
- GSK Investigational Site, New York
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
Recrutement en coursPhase 3
- GSK Investigational Site, New York
- GSK Investigational Site, New York
- GSK Investigational Site, New York
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Recrutement en coursPhase 2/3
- GSK Investigational Site, New York
- GSK Investigational Site, New York
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
Recrutement en coursPhase 2
- Icahn School of Medicine at Mount Sinai, New York
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Recrutement en cours
- Weill Cornell University Medical College, New York
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
Recrutement en coursPhase 3
- NYU Langone Health, New York
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Recrutement en coursÉtude observationnelle
- New York University Langone Medical Center, New York
- New York Presbyterian Hospital - Weill Cornell Medicine, New York
PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
Recrutement en coursÉtude observationnelle
- Weill Cornell Medicine, New York
Platform Clinical Study for Conquering Scleroderma
Recrutement en coursPhase 2
- Hospital for Special Surgery, New York
- Columbia University Medical Center, New York
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Recrutement en coursPhase 2/3
- Columbia University Irving Medical Center, New York
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Recrutement en coursÉtude observationnelle
- Weill Medical College of Cornell University, New York
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Recrutement en coursPhase 3
- Weill Cornell Medicine, New York-Presbyterian Hospital, New York
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
Recrutement en coursPhase 2
- aTyr Investigative Site, New York
Essais pour Maladies pulmonaires interstitielles dans d'autres villes
- Philadelphia, PA16 études
- Los Angeles, CA14 études
- Charleston, SC13 études
- Kansas City, KS13 études
- Durham, NC13 études
- Chicago, IL12 études
- Houston, TX12 études
- Aurora, CO11 études
- Ann Arbor, MI11 études
- Dallas, TX9 études
- Salt Lake City, UT9 études
- Boston, MA9 études
Autres études à New York City
- Cancer du sein136 études
- Cancer du poumon non à petites cellules121 études
- Cancer (tous types)109 études
- Cancer de la prostate103 études
- Cancer métastatique93 études
- Cancer colorectal78 études
- Cancer de l'ovaire69 études
- Cancer du poumon60 études
- Myélome multiple60 études
- Cancer du pancréas60 études
- Cancer de l'endomètre52 études
- Leucémie aiguë myéloïde51 études
Source : ClinicalTrials.gov, données récupérées le 6 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.